Clinical Outcomes of Uterine Carcinosarcoma Results of 94 Patients

Gokce Z. K., Turan T., Karalok A., Tasci T., Ureyen I., Ozkaya E., ...Daha Fazla

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.25, sa.2, ss.279-287, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1097/igc.0000000000000347
  • Dergi Adı: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.279-287
  • Anahtar Kelimeler: Carcinosarcoma, Malignant mixed mullerian tumor, Uterine neoplasm, Adjuvant therapy, Survival, GYNECOLOGIC-ONCOLOGY-GROUP, MIXED MULLERIAN TUMORS, PHASE-III TRIAL, STAGE-I, PROGNOSTIC-FACTORS, ADJUVANT-THERAPY, LOCAL-CONTROL, RADIOTHERAPY, SURVIVAL, SARCOMAS
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Objective: We aimed to determine the clinicopathologic features and identify prognostic factors of patients with uterine carcinosarcoma.